Synergistic Implantable Medical Device Delivery Systems
Legal Citation
Summary of the Inventive Concept
The present inventive concept integrates cutting-edge technologies, such as blockchain, AI, IoT, and advanced materials, with implantable medical device delivery systems to enhance device deployment, tracking, and performance monitoring.
Background and Problem Solved
The original patent disclosed limitations in implantable medical device delivery systems, including the lack of real-time tracking, inefficient inventory management, and limited data analysis capabilities. The present inventive concept addresses these limitations by introducing synergistic combinations of distinct technologies to create a more powerful and efficient system.
Detailed Description of the Inventive Concept
The inventive concept comprises a delivery system integrated with a blockchain-based authentication module, an AI-powered navigation module, and a sensor-enabled tip for real-time tracking of device deployment. Additionally, the system includes a storage device with a compartmentalized structure and an IoT-enabled tracking module for monitoring device inventory and location. The kit for implantable medical device delivery features a delivery catheter with a nanocoated surface for reduced friction and an AI-assisted planning module for optimizing device placement.
Novelty and Inventive Step
The present inventive concept's novelty lies in the synergistic integration of blockchain, AI, IoT, and advanced materials with implantable medical device delivery systems, providing a more efficient, accurate, and data-driven approach to device deployment and monitoring.
Alternative Embodiments and Variations
Alternative embodiments may include the integration of additional technologies, such as augmented reality or robotics, to further enhance the delivery system's capabilities. Variations may also include the use of different materials or geometries for the delivery catheter or storage device.
Potential Commercial Applications and Market
The present inventive concept has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular and peripheral vascular disease treatment. The target market includes hospitals, medical device manufacturers, and healthcare providers seeking to improve patient outcomes and reduce costs.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61F2/0095 |
| A | A61 | A61B50/30 |
| A | A61 | A61F2/2412 |
| A | A61 | A61F2/2436 |
| A | A61 | A61F2/24 |
| A | A61 | A61F2/46 |
| A | A61 | A61F2/9526 |
| A | A61 | A61L2300/404 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device delivery systems, specifically implantable device technologies with a focus on interventional cardiology and vascular interventions. Ordinary skill would involve advanced biomedical engineering, medical device design, and interdisciplinary knowledge of materials science, sensor technologies, and minimally invasive medical procedures
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degrees (MS/PhD), 5-10 years of experience in medical device development, proficient in catheter design, sensor integration, and understanding of clinical deployment requirements for implantable medical technologies
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies like blockchain, AI, and IoT into existing medical device delivery systems represents a predictable evolution of tracking and monitoring capabilities. The fundamental mechanical design principles from the source patent provide a clear foundation for incorporating advanced sensing and authentication technologies. These technological extensions represent logical incremental improvements that address known challenges in medical device deployment and tracking.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,404 |
|---|---|
| Title | Storage devices, loading devices, delivery systems, kits, and associated methods |
| Assignee(s) | Cook Medical Technologies LLC, Muffin Incorporated |